Immune checkpoint inhibitors in non-small cell lung cancer: from current perspectives to future treatments-a systematic review.

Alejandro Olivares-Hernández, Elísabet González Del Portillo,Álvaro Tamayo-Velasco,Luis Figuero-Pérez,Svetlana Zhilina-Zhilina,Emilio Fonseca-Sánchez,José Pablo Miramontes-González

Annals of translational medicine（2023）

引用 0|浏览4

暂无评分

摘要

Immunotherapy is the mainstay of NSCLC treatment in all stages, including adjuvant, neoadjuvant and advanced tumors. The development of new molecules will revolutionize the treatment of NSCLC in the coming years.

查看译文

关键词

cell lung cancer,lung cancer,future treatments—a,systematic review,inhibitors,non-small

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要